1. Epigenetics
  2. Epigenetic Reader Domain
  3. BRDT-IN-2

BRDT-IN-2 is a BRDT-BD1-preferring inhibitor (Ki=10 μM) with higher affinity for BRDT-BD1 than BRD4-BD1. BRDT-IN-2 preferentially binds BRDT-BD1 without direct interaction with BRDT-BD1’s Arg54 residue. BRDT-IN-2 binds BRD4-BD1 with lower affinity via structured water molecule displacement in its binding pocket. BRDT-IN-2 can be used for the research of multiple myeloma.

For research use only. We do not sell to patients.

BRDT-IN-2

BRDT-IN-2 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

BRDT-IN-2 is a BRDT-BD1-preferring inhibitor (Ki=10 μM) with higher affinity for BRDT-BD1 than BRD4-BD1. BRDT-IN-2 preferentially binds BRDT-BD1 without direct interaction with BRDT-BD1’s Arg54 residue. BRDT-IN-2 binds BRD4-BD1 with lower affinity via structured water molecule displacement in its binding pocket. BRDT-IN-2 can be used for the research of multiple myeloma[1].

IC50 & Target

BRDT (BD1)

 

In Vitro

BRDT-IN-2 inhibits the growth of MM.1S multiple myeloma cells with an IC50 of 6.8 μM[1].
BRDT-IN-2 (0.039-10.000 μM; 6 h) dose-dependently downregulates the expression of c-Myc protein in MM.1S multiple myeloma cells in in vitro treatments[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: MM.1S multiple myeloma cells
Concentration: 0.1% (final DMSO concentration)
Incubation Time: 72 hours (37 °C, 5% CO2)
Result: Inhibited MM.1S cell growth with an IC50 value of 6.8 μM.
Was less potent than reference inhibitors JQ1 (IC50 = 0.12 μM) and I-BET151 (IC50 = 0.33 μM).

Western Blot Analysis[1]

Cell Line: MM.1S multiple myeloma cells
Concentration: 0.039-10.000 μM
Incubation Time: 6 hours (37 °C, 5% CO2)
Result: Dose-dependently suppressed c-Myc protein levels.
Caused measurable reduction of c-Myc protein levels at concentrations ≥0.630 μM relative to untreated control cells.
Molecular Weight

728.79

Formula

C33H41FN8O8S

SMILES

CC1=C(NC2=CC(C(N[C@@H](CCC(O)=O)C(O)=O)=O)=CC(NS(=O)(C(C)(C)C)=O)=C2)N=C(NC3=CC(F)=C(C(NC4CCNCC4)=O)C=C3)N=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
BRDT-IN-2
Cat. No.:
HY-183248
Quantity:
MCE Japan Authorized Agent: